HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,704,176 | +1552.2% | 227,858 | +1460.0% | 0.02% | +2000.0% |
| Q2 2023 | $526,838 | -72.3% | 14,606 | -56.3% | 0.00% | -97.1% |
| Q4 2022 | $1,900,460 | +771.8% | 33,400 | +507.3% | 0.03% | +750.0% |
| Q3 2022 | $218,000 | -56.4% | 5,500 | -51.6% | 0.00% | -71.4% |
| Q2 2022 | $500,000 | +43.7% | 11,372 | +31.3% | 0.01% | +27.3% |
| Q4 2021 | $348,000 | +6.4% | 8,663 | -59.0% | 0.01% | -42.1% |
| Q3 2019 | $327,000 | -62.4% | 21,120 | -58.3% | 0.02% | -80.2% |
| Q2 2019 | $870,000 | – | 50,610 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |